Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia

NCT05728944 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

229

Enrollment

OTHER

Sponsor class

Conditions

Presbyopia
Near Vision
Refractive Error
Eye Diseases

Interventions

DRUG: Aceclidine+Brimonidine combination ophthalmic solution
DRUG: Aceclidine ophthalmic solution
DRUG: Vehicle

Sponsor

LENZ Therapeutics, Inc